AMICUS THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Princeton, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
AMICUS THERAPEUTICS, INC. has filed 2,174 SEC EDGAR filings since 25 Jul 2002

SEC filing history

Showing 951-975 of 1,000 matching filings.

Per page
25
Current page
39
4

FORM 4 SUBMISSION

Filing date
19 Apr 2018
Reporting date
17 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Apr 2018
Reporting date
16 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Apr 2018
Reporting date
12 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33497

PRE 14A

Filing date
13 Apr 2018
Reporting date
07 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33497

8-K

Filing date
23 Mar 2018
Reporting date
22 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2018
Reporting date
05 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Mar 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33497

8-K

Filing date
16 Feb 2018
Reporting date
15 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-211005

424B5

Filing date
16 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83043

SC 13G/A filing

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-211005

424B5

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83043

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83043

SC 13G filing

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83043

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83043

AMICUS THERAPEUTICS, INC.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83043

MS AMENDMENT

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83043

SC 13G/A filing

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33497

8-K

Filing date
12 Feb 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .